Dr. David Sullivan, a professor in the Johns Hopkins Bloomberg School of Public Health Department of Molecular Microbiology and Immunology, has received an $1.3 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to train doctoral students and postdoctoral fellows in the molecular aspects of malaria and mosquito arboviral biology and pathogenesis. Trainees will also learn about the ecology and epidemiology of mosquito-borne pathogens and the role of mosquito vectors in transmission.
The PhD students and postdoctoral fellows will study the public health implications of the mosquito and its role as a vector to diseases including dengue, Zika and malaria. The trainees will work with 26 Bloomberg School faculty, representing three focus areas — microbiology, epidemiology, and pharmacology. The grant runs through June 2024.
The goal of the training program is to provide trainees with a firm foundation in the basic disciplines necessary for the study of mosquito-borne diseases. Trainees will gain critical perspective that will enable them to apply their knowledge creatively to public health problems.
Dr. Sullivan, an infectious diseases physician, is also a professor at the Johns Hopkins Malaria Research Institute and at the Center for Global Health. His research focuses on malaria diagnosis, drugs, molecular biology related to iron, and pathology related to severe anemia. Dr. Sullivan and his team of researchers are currently engaged in testing and developing novel malaria drugs.Tags: Friday Letter Submission, Publish on January 17